Physician validation
Direct access to the cardiologists and electrophysiologists who validate the technology and drive its adoption — clinical due diligence embedded before institutional capital.
Deploy capital through SPVs (per-deal) or our upcoming fund — with institutional-grade governance, compliance infrastructure, and direct access to the cardiologists who validate the technology and drive adoption.
Direct access to the cardiologists and electrophysiologists who validate the technology and drive its adoption — clinical due diligence embedded before institutional capital.
Deploy capital through SPVs on a per-deal basis, or across a thesis-driven portfolio through our upcoming fund.
Institutional-grade governance, compliance infrastructure, and transparent terms.
Companies already clinically validated and aligned to clear strategic-buyer demand in cardiovascular medtech.
For informational purposes only. Participation is limited to accredited investors and is made only through definitive offering documents.
Shape what gets built and share in the value you help create.
More than capital: physician validation, repositioning, and a path to strategic value.
SPV syndication into deals already clinically validated and positioned.
An external innovation radar surfacing physician-validated companies.
Founders, investors, physicians, and strategic partners in cardiovascular and electrophysiology medtech — we would welcome a conversation.
Get in touch →Miami, Florida